Please login to the form below

Not currently logged in

Belantamab mafodotin

This page shows the latest Belantamab mafodotin news and features for those working in and with pharma, biotech and healthcare.

GSK’s anti-BCMA drug leads crowded CHMP recommendations

GSK’s anti-BCMA drug leads crowded CHMP recommendations

That includes a recommendation for a conditional marketing approval for GlaxoSmithKline’s new antibody drug conjugate Blenrep (belantamab mafodotin).

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...